3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine | 80751-85-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 3-Methyl-6-chloro-2,3,4,5-tetrahydro-7,8-dihydroxy-1-(3-methylphenyl)-1H-3-benzazepine
• 英文别名: 9-chloro-3-methyl-5-(3-methylphenyl)-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol
• CAS: 80751-85-5
• 化学式: C₁₈H₂₀ClNO₂
• 分子量: 317.8
• InChiKey: JXMYTVOBSFOHAF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  22
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  43.7
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• MODULATORS OF TUMOR IMMUNE RESISTANCE FOR THE TREATMENT OF CANCER
  申请人：Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts

  公开号：EP3416640A1

  公开（公告）日：2018-12-26
• MODULATORS OF CCR9 FOR TREATING TUMOR RESISTANCE TO IMMUNE RESPONSES
  申请人：Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts

  公开号：EP3416641A1

  公开（公告）日：2018-12-26
• Dual function drugs and uses thereof
  申请人：Altar A. Charles

  公开号：US20070142399A1

  公开（公告）日：2007-06-21

  Dual action compounds are provided that are inhibitors of catechol-omethyltransferase (COMT) enzyme and are also partial agonists or antagonists of the D2 receptor, or agonists of the D1 receptor, or interact in these ways with both D1 and D2 receptors. Use of the compounds for treating neuropsychiatric disorders, particularly schizophrenia and mild cognitive impairment, is also described.
• Manipulation of brain CDP-diacylglycerol and uses thereof
  申请人：Tyeryar Kimberly R.

  公开号：US20080039443A1

  公开（公告）日：2008-02-14

  Provided herein methods of screening for potential antidepressant compounds effective to increase production of cellular CDP-diacylglycerol and synthesis of inositol phospholipid in depression-related areas of the brain. Also, provided are methods of diagnosing and treating depressive or mood disorders in a subject by administering these screened antidepressant compounds. Further provided is a method of determining the therapeutic efficacy of an antidepressant drug regimen by comparing the ratio of CDP-diacylglycerol/inositol phosphate after treatment to a basal ratio in a subject.
• Measurement of Brain CDP-Diacylglycerol Synthase 1 Enzyme and Uses Thereof
  申请人：Undieh Ashiwel S.

  公开号：US20130022978A1

  公开（公告）日：2013-01-24

  Provided herein are methods of diagnosing depressive disorders in a subject by comparing a CDP-diacylglycerol synthase 1 enzyme activity or expression level to enzyme activity or expression level of CDP-diacylglycerol synthase 1 in a control subject. Also herein are methods of predicting therapeutic efficacy of an antidepressant drug in a subject with depressive disorders by monitoring enzyme activity or expression level of CDP-diacylglycerol synthase 1 in the subject. Further provided herein are methods of identifying a compound effective to treat or alleviate the symptoms of depression by monitoring enzyme activity or expression level of CDP-diacylglycerol synthase 1 in a tissue. Further provided are kits for diagnosing depressive disorders.